Precision Biosensor Inc is a Korea-based company primarily engaged in the development, manufacture and sale of in vitro diagnostic devices and reagents. The Company manufactures and sells clinical chemical diagnostic products such as human and veterinary testers and cartridges. The Company also manufactures and sells immunodiagnostic products such as time-resolved fluorescence products and gold products. The company sells its products in domestic and overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	₩1,435.00	+0.28%	9,544
29/10/26	₩1,431.00	-0.69%	11,106
28/10/26	₩1,441.00	-0.41%	12,026
27/10/26	₩1,447.00	-2.23%	6,273
26/10/26	₩1,480.00	+1.09%	4,990

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 30/10/2026			5-day change	1st Jan Change
1,435.00 ^KRW	+0.28%		-1.98%	-45.95%

02-01	Precision Biosensor, Inc. completed the acquisition of CT BIO Co., Ltd.	CI
11-14	Precision Biosensor, Inc. agreed to acquire CT BIO Co., Ltd. for KRW 11.1 billion.	CI

Market Cap	31.5B 23.62M 21.15M 19.45M 17.63M 32.95M 2.24B 33.57M 232M 93.13M 1.18B 88.63M 86.74M 3.72B	P/E 2024	-4.49x	P/E 2025	-3.34x
Enterprise Value	35.69B 26.76M 23.97M 22.05M 19.98M 37.34M 2.54B 38.04M 263M 106M 1.34B 100M 98.3M 4.22B	EV / Sales 2024	2.44x	EV / Sales 2025	2.6x
Free-Float	40.1%	Yield 2024 *	-	Yield 2025	-

02-01	Precision Biosensor, Inc. completed the acquisition of CT BIO Co., Ltd.	CI
11-14	Precision Biosensor, Inc. agreed to acquire CT BIO Co., Ltd. for KRW 11.1 billion.	CI
11-03	Precision Biosensor, Inc. announced that it has received KRW 17.00000112 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
17/10/25	Precision Biosensor, Inc. announced that it expects to receive KRW 17.00000112 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
02/10/24	Kwang Dong Pharmaceutical Co., Ltd. completed the acquisition of 29.7% stake in Precision Biosensor, Inc. from i-SENS, Inc. from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo.	CI
02/07/24	Kwang Dong Pharmaceutical Co., Ltd. agreed to acquire 29.7% stake in Precision Biosensor, Inc. from i-SENS, Inc. from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo for KRW 16.9 billion.	CI
25/03/24	Qlife Signs Letter of Intent with Precision Biosensor	CI
08/02/24	Precision Biosensor, Inc. announced that it has received KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd.	CI
06/02/24	Precision Biosensor, Inc. announced that it expects to receive KRW 3 billion in funding from Shinhan Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd. and another investor	CI
19/09/22	Precision Biosensor, Inc.(KOSDAQ:A335810) dropped from S&P Global BMI Index	CI
18/11/21	Precision Biosensor, Inc. announced that it has received KRW 150 billion in funding	CI
16/11/21	Precision Biosensor, Inc. announced that it expects to receive KRW 150 billion in funding	CI
21/06/21	Precision Biosensor, Inc.(KOSDAQ:A335810) added to S&P Global BMI Index	CI

28/05/24	QLIFE HOLDING AB, Interim Report Q1, January to March 2024	AQ
25/03/24	Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships	AQ

Precision Biosensor, Inc. Stock

Stocks

A335810

KR7335810008

Medical Equipment, Supplies & Distribution

Valuation: Precision Biosensor, Inc.

Chart: Precision Biosensor, Inc.

Latest news: Precision Biosensor, Inc.

Press Releases: Precision Biosensor, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Precision Biosensor, Inc.

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

1 day	+0.28%
1 week	-1.98%
Current month	-3.69%
1 month	-3.69%
3 months	+19.68%
6 months	-36.64%
Current year	-45.95%

1 week	1,370	1,509
1 month	1,361	1,549
Current year	1,106	3,345
1 year	1,106	3,505
3 years	1,106	6,350
5 years	1,106	14,000
10 years	1,106	41,000

Manager	Title	Age	Since
Han-Sin Kim CEO	Chief Executive Officer	58	01/05/2018
Jun-Hong Min CTO	Chief Tech/Sci/R&D Officer	56	-
Moon-Seon Hwang CTO	Chief Tech/Sci/R&D Officer	55	01/09/2022

Director	Title	Age	Since
Sung-Won Choi BRD	Director/Board Member	56	-
Hyuk-Jong Lee BRD	Director/Board Member	56	-
Han-Sin Kim BRD	Director/Board Member	58	01/05/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PRECISION BIOSENSOR, INC.	+0.28%	-1.98%	-44.38%	-71.86%	23.62M
ABBOTT LABORATORIES	+1.56%	+2.41%	-14.82%	+14.19%	184B
STRYKER CORPORATION	-6.38%	-4.98%	-20.90%	+11.15%	112B
MEDTRONIC PLC	-0.59%	+1.18%	+6.12%	+37.97%	118B
ESSILORLUXOTTICA	+3.42%	+1.71%	-42.32%	+9.52%	94.58B
CENCORA, INC.	+0.09%	-0.05%	-3.04%	+78.44%	63.13B
HOYA CORPORATION	-0.46%	+0.42%	+8.19%	+82.97%	55.66B
BECTON, DICKINSON AND COMPANY	-0.23%	-0.52%	+10.31%	-21.19%	53.9B
IDEXX LABORATORIES, INC.	-4.30%	-1.64%	-12.30%	+39.06%	43.42B
ALCON INC.	+0.58%	+2.00%	-1.07%	-6.43%	34.68B
Average	-0.60%	-0.25%	-11.42%	+17.38%	75.93B
Weighted average by Cap.	-0.49%	+0.23%	-10.66%	+25.21%

	2024	2025
Net sales	19.13B 14.35M 12.85M 11.82M 10.71M 20.02M 1.36B 20.39M 141M 56.58M 717M 53.84M 52.69M 2.26B	19.93B 14.94M 13.38M 12.31M 11.15M 20.84M 1.42B 21.23M 147M 58.92M 746M 56.07M 54.87M 2.35B
Net income	-7.31B -5.48M -4.91M -4.51M -4.09M -7.64M -520M -7.79M -53.81M -21.6M -274M -20.55M -20.12M -863M	-10.02B -7.51M -6.73M -6.19M -5.61M -10.48M -714M -10.68M -73.82M -29.64M -375M -28.2M -27.6M -1.18B
Net Debt	13.84B 10.38M 9.3M 8.55M 7.75M 14.48M 986M 14.75M 102M 40.94M 518M 38.96M 38.13M 1.64B	4.2B 3.15M 2.82M 2.59M 2.35M 4.39M 299M 4.47M 30.92M 12.41M 157M 11.81M 11.56M 496M